October 03, 2025

Triglyceride-Glucose Index Predicts Coronary Complexity

Researchers evaluate TyG index as a marker to identify severe coronary anatomy in NSTEMI.

Conexiant

October 01, 2025

How Safe Are FDA-Cleared AI Tools?

“These findings indicate that standardized efficacy, safety, and risk assessment reporting remains inadequate for FDA-cleared AI/ML devices, underscoring the need for dedicated regulatory pathways and robust postmarket surveillance to ensure patient safety."

Conexiant

September 29, 2025

Meta-Analysis Finds Higher Cardiovascular Risk in IPF

Cardiovascular disease occurs more often in patients with idiopathic pulmonary fibrosis.

Conexiant

September 24, 2025

Beta-Blockers After MI: BETAMI–DANBLOCK Trial

Largest contemporary randomized trial demonstrates benefit following myocardial infarction in patients with preserved or mildly reduced ejection fraction.

Conexiant

September 24, 2025

Surgery Versus GLP-1: Long-Term Diabetes Outcomes

Metabolic surgery associated with lower mortality and retinopathy risk versus glucagon-like peptide-1 therapy in diabetes and obesity.

Conexiant

September 17, 2025

‘Death by a Thousand Cuts’

Rural South Texas hospitals and physicians face mounting strain as rising uninsured rates and federal funding cuts threaten access to essential health care.

KFF Health News

September 12, 2025

FDA Considers Ending Routine Advisory Committees on New Drugs

The FDA move to limit advisory committee involvement in drug approvals has prompted debate on the balance between efficiency and transparency.

KFF Health News

September 09, 2025

Glipizide Linked to 13% Higher Heart Risk

Sulfonylurea choice after metformin affects long-term cardiovascular event likelihood.

Conexiant

September 05, 2025

Dr. Jordan Strom Lays the Scene for ASE 2025

As ASE marks its 50th anniversary in Nashville, the meeting will showcase the latest echocardiography research, updated guidelines, the Kalmanson Lecture, and discussions on workforce challenges.

Conexiant